Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (22238)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Yang JC, Lu CW, Lin CJ. Treatment of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i18/5283.htm |
| Number | Citing Articles |
| 1 |
Hassan Salmanroghani, Massoud Mirvakili, Mahmud Baghbanian, Roham Salmanroghani, Golshid Sanati, Pouria Yazdian, John Green. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial. PLOS ONE 2018; 13(6): e0197096 doi: 10.1371/journal.pone.0197096
|
| 2 |
Marco Gasparetto, Caterina Strisciuglio, Amit Assa, Kostantinos Gerasimidis, Federica Giachero, Jan Novak, Philip Robinson, Bálint Tél, Matthias Zilbauer, Andreas Jenke. Making Research Flourish Through ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(2): 301 doi: 10.1097/MPG.0000000000003250
|
| 3 |
Patrick Joseph Tempera, Mark Michael, Omar Tageldin, Stephen Hasak. Gastric Cancer Due to Chronic H. pylori Infection: What We Know and Where We Are Going. Diseases 2022; 10(3): 57 doi: 10.3390/diseases10030057
|
| 4 |
Assessment of Drug Treatment Practices and Pattern for Gastroenteritis Among Under-Five Children in A Tertiary Hospital in Southeast Nigeria. International Journal of Pharmacy and Infections Therapy 2021; : 1 doi: 10.31829/2765-852X/ijpit2021-4(1)-118
|
| 5 |
Dian Wang, Dafeng Wang, Kai Liao, Biqi Zhang, Shuai Li, Minghui Liu, Linjie Lv, Feng Xue. Optical detection using CRISPR-Cas12a of Helicobacter pylori for veterinary applications. Microchimica Acta 2023; 190(11) doi: 10.1007/s00604-023-06037-x
|
| 6 |
Yue Zhou, Lei Tao, Jiahao Qiu, Jing Xu, Xinyu Yang, Yu Zhang, Xinyu Tian, Xinqi Guan, Xiaobo Cen, Yinglan Zhao. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01823-2
|
| 7 |
Seong Ju Lee, Yun Jeong Lim, Seok Bo Hong, Ji Hyung Nam, Dong Kee Jang, Hyoun Woo Kang, Jae Hak Kim, Jun Kyu Lee, Moon-Su Koh, Jin Ho Lee. Standard First-line Triple Therapy forHelicobacter pyloriInfection: A Comparison of Eradication Rates Based on Timing of Administration of Proton Pump Inhibitors. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(2): 115 doi: 10.7704/kjhugr.2018.18.2.115
|
| 8 |
Hassan Seddik, Jihane Benass, Sanaa Berrag, Asmae Sair, Reda Berraida, Hanae Boutallaka. Optimized sequential therapy <i>vs</i> 10- and 14-d concomitant therapy for eradicating <i>Helicobacter pylori</i>: A randomized clinical trial. World Journal of Gastroenterology 2024; 30(6): 556-564 doi: 10.3748/wjg.v30.i6.556
Abstract(330) |
Core Tip(326) |
Full Article(HTML)(2281)
|
Full Article with Cover (PDF)-735K(136)
|
Full Article (Word)-201K(12)
|
Audio-940K(7)
|
Peer-Review Report-206K(48)
|
Answering Reviewers-124K(53)
|
Full Article (PDF)-484K(140)
|
Full Article (XML)-99K(42)
|
Times Cited (0)
|
Total Visits (5249)
|
Open
|
| 9 |
Andrés González, Sandra Salillas, Adrián Velázquez-Campoy, Vladimir Espinosa Angarica, María F. Fillat, Javier Sancho, Ángel Lanas. Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47746-9
|
| 10 |
Peiyu Chen, Linkai Li, Hongli Wang, Junhong Zhao, Yang Cheng, Jing Xie, Meiwan Cao, Ling Huang, Fangying Yang, Huan Chen, Jiayu Chen, Mingmin Su, Yuxin Xu, Fengfeng Zheng, Lanlan Geng, Wanfu Xu, Sitang Gong. Omeprazole, an inhibitor of proton pump, suppresses De novo lipogenesis in gastric epithelial cells. Biomedicine & Pharmacotherapy 2020; 130: 110472 doi: 10.1016/j.biopha.2020.110472
|
| 11 |
Elianna Dunster, William L. Johnson, Rachel A. F. Wozniak. Antimicrobial Drug–Drug Interactions in the Treatment of Infectious Keratitis. Cornea 2023; 42(12): 1555 doi: 10.1097/ICO.0000000000003304
|
| 12 |
Cailing Li, Yanyan Shi, Baojun Suo, Xueli Tian, Liya Zhou, Zhiqiang Song. PPI‐amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta‐analysis. Helicobacter 2021; 26(4) doi: 10.1111/hel.12816
|
| 13 |
Lucas Mainardo Rodrigues Bezerra, Sandyla Leite de Sousa, Guilherme Tertuliano Silva Macedo, Igor Thiago Pinheiro Passos, Luiz De Moura Correia Filho, Cedric Maia Muribeca, Lucas Pereira de Carvalho , Giovana Sardi de Freitas Alvarez Lopes, Gisella Maria Santos Pereira , Lorenna Kellyne Rodrigues Baldoino . TRATAMENTO DA ÚLCERA GÁSTRICA RELACIONADA AO HELICOBACTER PYLORI: ABORDAGENS CIRÚRGICAS E CONSERVADORAS - UMA REVISÃO BIBLIOGRÁFICA. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 2024; 5(4): e545103 doi: 10.47820/recima21.v5i4.5103
|
| 14 |
Isabel Casanovas Moreno-Torres. Encyclopedia of Infection and Immunity. 2022; : 685 doi: 10.1016/B978-0-12-818731-9.00103-8
|
| 15 |
Jyh‐Chin Yang, John Y. Kao. Treatment considerations in Helicobacter pylori management. Alimentary Pharmacology & Therapeutics 2022; 55(S1) doi: 10.1111/apt.16652
|
| 16 |
Hyasinta Jaka, Andreas Mueller, Christa Kasang, Stephen E. Mshana. Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4085-1
|
| 17 |
Wenxiu Zhang, Zaofeng Yang, Jiale Zheng, Kaili Fu, Jack Ho Wong, Yunbi Ni, Tzi Bun Ng, Chi Hin Cho, Michael K. Chan, Marianne M. Lee. A Bioresponsive Genetically Encoded Antimicrobial Crystal for the Oral Treatment of Helicobacter Pylori Infection. Advanced Science 2023; 10(30) doi: 10.1002/advs.202301724
|
| 18 |
Qian Luo, Na Liu, Sugui Pu, Ze Zhuang, Hang Gong, Dekui Zhang. A review on the research progress on non-pharmacological therapy of Helicobacter pylori. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1134254
|
| 19 |
Seung Min Shin, Yun Jeong Lim, Yeo Jin Yoon, Hyoun Woo Kang, Jae Hak Kim, Jun Kyu Lee, Moon-Su Koh, Jin Ho Lee. Recent First Line Eradication Rate ofHelicobacter pyloriInfection: Single Center Experience. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(2): 108 doi: 10.7704/kjhugr.2015.15.2.108
|
| 20 |
Kevin Pak, Zachary Junga, Andrew Mertz, Manish Singla. The Patterns and Associated Cost of Serologic Testing for Helicobacter pylori in the U.S. Military Health System. Military Medicine 2020; 185(9-10): e1417 doi: 10.1093/milmed/usaa141
|
| 21 |
Jyh-Chin Yang, Chun-Jung Lin, Hong-Long Wang, Jin-De Chen, John Y. Kao, Chia-Tung Shun, Chien-Wei Lu, Bor-Ru Lin, Ming-Jium Shieh, Ming-Chu Chang, Yu-Ting Chang, Shu-Chen Wei, Lin-Chih Lin, Wen-Chun Yeh, Jen-Shin Kuo, Chien-Chih Tung, Yew-Loong Leong, Teh-Hong Wang, Jau-Min Wong. High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection. Clinical Gastroenterology and Hepatology 2015; 13(5): 895 doi: 10.1016/j.cgh.2014.10.036
|
| 22 |
Yuan-Yuan Dai, Chun Qin, Gan-Rong Huang, Yan-Chun Qin, Yong-Yi Huang, Yan-Qiang Huang, Li-juan Zhao. Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori. Antimicrobial Agents and Chemotherapy 2022; 66(7) doi: 10.1128/aac.00073-22
|
| 23 |
Yuichiro Noiri, Ryoko Nagata. Current status of gastric and oral infection/diseases caused by Helicobacter pylori. Oral Science International 2023; 20(3): 182 doi: 10.1002/osi2.1172
|
| 24 |
Ayman Fathy El Sayed, Ayman Magd Eldin Mohammad Sadek, Walid Ahmed Ragab Abdelhamid. Comparison between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized Trial. Middle East Journal of Digestive Diseases 2021; 13(3): 223 doi: 10.34172/mejdd.2021.229
|
| 25 |
Carlos L. Arteaga, Peter C. Adamson, Jeffrey A. Engelman, Margaret Foti, Richard B. Gaynor, Susan G. Hilsenbeck, Paul J. Limburg, Scott W. Lowe, Elaine R. Mardis, Scott Ramsey, Timothy R. Rebbeck, Andrea L. Richardson, Eric H. Rubin, George J. Weiner. AACR Cancer Progress Report 2014. Clinical Cancer Research 2014; 20(19_Supplement): S1 doi: 10.1158/1078-0432.CCR-14-2123
|
| 26 |
Paula Parreira, Belinda I.G. Soares, Carmen S.R. Freire, Armando J.D. Silvestre, Celso A. Reis, M. Cristina L. Martins, Maria F. Duarte. Eucalyptus spp. outer bark extracts inhibit Helicobacter pylori growth: in vitro studies. Industrial Crops and Products 2017; 105: 207 doi: 10.1016/j.indcrop.2017.05.012
|
| 27 |
Ronita De, Avijit Sarkar, Prachetash Ghosh, Mou Ganguly, Bipul Chandra Karmakar, Dhira Rani Saha, Aniket Halder, Abhijit Chowdhury, Asish K Mukhopadhyay. Antimicrobial activity of ellagic acid against Helicobacter pylori isolates from India and during infections in mice. Journal of Antimicrobial Chemotherapy 2018; 73(6): 1595 doi: 10.1093/jac/dky079
|
| 28 |
Luana Kauany de Sá Santos, Jonathan Santos Apolonio, Beatriz Rocha Cuzzuol, Bruna Teixeira da Costa, Vinícius Lima de Souza Gonçalves, Ronaldo Teixeira da Silva Júnior, Marcel Silva Luz, Fabian Fellipe Bueno Lemos, Samuel Luca Rocha Pinheiro, Fabrício Freire de Melo. <i>Helicobacter pylori</i> infection in pregnant women: Gastrointestinal symptoms and pregnancy- related disorders. World Journal of Clinical Infectious Diseases 2023; 13(5): 49-57 doi: 10.5495/wjcid.v13.i5.49
Abstract(715) |
Core Tip(629) |
Full Article(HTML)(14354)
|
Full Article with Cover (PDF)-1167K(98)
|
Full Article (Word)-536K(20)
|
Audio-587K(14)
|
Peer-Review Report-180K(48)
|
Answering Reviewers-105K(55)
|
Full Article (PDF)-953K(238)
|
Full Article (XML)-133K(52)
|
Times Cited (0)
|
Total Visits (18692)
|
Open
|
| 29 |
Cheng-Jung Yao, Shu-Jyuan Yang, Chung-Huan Huang, Yuan-Ting Chang, Chung-Hao Wang, Ming-Jium Shieh, Tai-Horng Young. Retention Time Extended by Nanoparticles Improves the Eradication of Highly Antibiotic-Resistant Helicobacter pylori. Pharmaceutics 2022; 14(10): 2117 doi: 10.3390/pharmaceutics14102117
|
| 30 |
Zheyu Wang, Fen Wang. Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221125308
|
| 31 |
Vanessa Baratta, Jason Own, Chiara Di Renzo, Jenna Ollodart, John P. Geibel, Maria Barahona. In Pursuit of the Parietal Cell – An Evolution of Scientific Methodology and Techniques. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.01497
|
| 32 |
Amin Talebi Bezmin Abadi. Vaccine against <i>Helicobacter pylori</i>: Inevitable approach. World Journal of Gastroenterology 2016; 22(11): 3150-3157 doi: 10.3748/wjg.v22.i11.3150
|
| 33 |
Shuang Zhang, Yu Wang, Fang Lu, Shadi A. D. Mohammed, Hanxing Liu, Song Ding, Shu-min Liu. Mechanism of Action of Shenerjiangzhi Formulation on Hyperlipidemia Induced by Consumption of a High-Fat Diet in Rats Using Network Pharmacology and Analyses of the Gut Microbiota. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.745074
|
| 34 |
|
| 35 |
Shan Xu, Xiaohong Wu, Enguo Chen, Kejing Ying. Anti‐Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature. The Clinical Respiratory Journal 2024; 18(8) doi: 10.1111/crj.13816
|
| 36 |
Mohsen Razavizadeh, Abbas Arj, Maryam Madani, Hamidreza Gilassi. Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection. Acta Medica (Hradec Kralove, Czech Republic) 2020; 63(4): 183 doi: 10.14712/18059694.2020.61
|
| 37 |
Thomas Regnath, Olaf Raecke, Axel Enninger, Ralf Ignatius. Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany. Helicobacter 2017; 22(1) doi: 10.1111/hel.12327
|
| 38 |
Li-Wei Chen, Liang-Che Chang, Chung-Ching Hua, Ching-Jung Liu, Tien-Shin Chou, Chih-Lang Lin, Rong-Nan Chien. The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Helicobacter pylori Eradication: An Open-Label Random Trial. Journal of Clinical Medicine 2021; 10(19): 4352 doi: 10.3390/jcm10194352
|
| 39 |
Carlotta F. ZIZZI, Rinaldo PELLICANO, Luigi BIANCONE. The relationship between Helicobacter pylori and chronic kidney disease: update 2020. Minerva Gastroenterologica e Dietologica 2021; 66(4) doi: 10.23736/S1121-421X.20.02729-4
|
| 40 |
Constantin Foja, Stefan Senekowitsch, Fabian Winter, Michael Grimm, Christoph Rosenbaum, Mirko Koziolek, Maximilian Feldmüller, Marie-Luise Kromrey, Eberhard Scheuch, Mladen V. Tzvetkov, Werner Weitschies, Philipp Schick. Prolongation of the gastric residence time of caffeine after administration in fed state: Comparison of effervescent granules with an extended release tablet. European Journal of Pharmaceutics and Biopharmaceutics 2024; 199: 114313 doi: 10.1016/j.ejpb.2024.114313
|
| 41 |
Roberto Grosso, M.-Violante de-Paz. Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations. Pharmaceutics 2022; 14(7): 1340 doi: 10.3390/pharmaceutics14071340
|
| 42 |
Anastasia Dmitrieva, Oksana Kozlova, Victor Atuchin, Irina Milentieva, Anna Vesnina, Svetlana Ivanova, Lyudmila Asyakina, Alexander Prosekov. Study of the Effect of Baicalin from Scutellaria baicalensis on the Gastrointestinal Tract Normoflora and Helicobacter pylori. International Journal of Molecular Sciences 2023; 24(15): 11906 doi: 10.3390/ijms241511906
|
| 43 |
Darsh Gautam, Poonam Talwan, Sahil Dhiman, Rahul Gill, Aparna Thakur, Simran Dhiman, Deexa Sharma, Akhil Kumar, Saksham Sharma. Amoxicillin-loaded Nanotechnological Carriers for the Effective
Treatment of Helicobacter pylori Infection. Micro and Nanosystems 2023; 15(4): 245 doi: 10.2174/0118764029259927231127094657
|
| 44 |
WonGun Kwack, YunJeong Lim, ChiYeon Lim, David Y. Graham. High Dose Ilaprazole/Amoxicillin as First-Line Regimen forHelicobacter pyloriInfection in Korea. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/1648047
|
| 45 |
Mohammad Mahdi Nasehi, Mohammad Effatpanah, Mohammad Gholamnezhad, Hossein Karami, Maryam Ghamkhar, Nezam Armand, Yasmin Heydarzadeh Sohi, Reza Mehrizi, Leila Ghamkhar. Antibiotic prescription prevalence in Iranian outpatients: A focus on defined daily doses and the AWaRe classification system. American Journal of Infection Control 2024; 52(12): 1359 doi: 10.1016/j.ajic.2024.07.007
|
| 46 |
Chunxi Shu, Zhou Xu, Cong He, Xinbo Xu, Yanan Zhou, Baihui Cai, Yin Zhu. Application of biomaterials in the eradication of Helicobacter pylori: A bibliometric analysis and overview. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1081271
|
| 47 |
Roberto Grosso, Elena Benito, Ana I. Carbajo-Gordillo, Manuel Jesús Díaz, M. Gracia García-Martín, M.-Violante de-Paz. Advanced interpenetrating polymer networks for innovative gastroretentive formulations targeting Helicobacter pylori gastric colonization. European Journal of Pharmaceutical Sciences 2024; 200: 106840 doi: 10.1016/j.ejps.2024.106840
|
| 48 |
Majid Eslami, Bahman Yousefi, Parviz Kokhaei, Ali Jazayeri Moghadas, Bizhan Sadighi Moghadam, Vahid Arabkari, Zohreh Niazi. Are probiotics useful for therapy of Helicobacter pylori diseases?. Comparative Immunology, Microbiology and Infectious Diseases 2019; 64: 99 doi: 10.1016/j.cimid.2019.02.010
|
| 49 |
Yu Wang, Jiang Du, Xuemei Wu, Ahmed Abdelrehem, Yu Ren, Chao Liu, Xuan Zhou, Sinan Wang. Crosstalk between autophagy and microbiota in cancer progression. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01461-0
|
| 50 |
Javier P. Gisbert. Optimization Strategies Aimed to Increase the Efficacy of Helicobacter pylori Eradication Therapies with Quinolones. Molecules 2020; 25(21): 5084 doi: 10.3390/molecules25215084
|
| 51 |
Maurício Palmeira Chaves de Souza, Bruna Almeida Furquim de Camargo, Larissa Spósito, Giovanna Capaldi Fortunato, Gabriela Corrêa Carvalho, Gabriel Davi Marena, Andréia Bagliotti Meneguin, Taís Maria Bauab, Marlus Chorilli. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment ofHelicobacter pyloriinfections. Critical Reviews in Microbiology 2021; 47(4): 435 doi: 10.1080/1040841X.2021.1895721
|
| 52 |
Lynne V McFarland, Ying Huang, Lin Wang, Peter Malfertheiner. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy forHelicobacter pylorieradication and prevention of adverse events. United European Gastroenterology Journal 2016; 4(4): 546 doi: 10.1177/2050640615617358
|
| 53 |
Mingyang Yu, Rongguang Zhang, Peng Ni, Shuaiyin Chen, Guangcai Duan, Rosa del Campo. Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. PLOS ONE 2019; 14(10): e0223309 doi: 10.1371/journal.pone.0223309
|
| 54 |
Shu-Jyuan Yang, Chung-Huan Huang, Jyh-Chin Yang, Chung-Hao Wang, Ming-Jium Shieh. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency ofHelicobacter pylori. ACS Applied Materials & Interfaces 2020; 12(49): 54316 doi: 10.1021/acsami.0c13101
|
| 55 |
Zain Sharif, Muaz Mubashir, Mehdi Naqvi, Hassan Atique, Saira Mahmood, Muneeb Ullah. Randomized Clinical Trial on the Efficacy of Triple Therapy Versus Sequential Therapy in Helicobacter pylori Eradication. Cureus 2022; doi: 10.7759/cureus.24897
|
| 56 |
Abbas Arj, Marzieh Mollaei, Mohsen Razavizadeh, Alireza Moraveji. The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication. Journal of Research in Pharmacy Practice 2020; 9(2): 101 doi: 10.4103/jrpp.JRPP_19_86
|
| 57 |
Susanne Jenneke Van Veen, Elvira Ingrid Levy, Koen Huysentruyt, Yvan Vandenplas. Clinical Dilemmas for the Diagnosis and Treatment of Helicobacter pylori Infection in Children: From Guideline to Practice. Pediatric Gastroenterology, Hepatology & Nutrition 2024; 27(5): 267 doi: 10.5223/pghn.2024.27.5.267
|
| 58 |
Yanchun Gao, Ruihong Wang, Lin Liu, Shitao Feng, Xiaozhi Xi, Wengong Yu, Yuchao Gu, Ye Wang. Identification and characterization of shark VNARs targeting the Helicobacter pylori adhesin HpaA. Artificial Cells, Nanomedicine, and Biotechnology 2023; 51(1): 509 doi: 10.1080/21691401.2023.2255635
|
| 59 |
Zhi-Ning Ye, Harry Hua-Xiang Xia, Ran Zhang, Lan Li, Li-Hao Wu, Xu-Juan Liu, Wen-Rui Xie, Xing-Xiang He, Fa-Ming Zhang. The Efficacy of Washed Microbiota Transplantation on Helicobacter pylori Eradication: A Pilot Study. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/8825189
|
| 60 |
Kamila Goderska, Sonia Agudo Pena, Teresa Alarcon. Helicobacter pylori treatment: antibiotics or probiotics. Applied Microbiology and Biotechnology 2018; 102(1): 1 doi: 10.1007/s00253-017-8535-7
|
| 61 |
Li Yang, Aitian Li, Ying Wang, Yi Zhang. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduction and Targeted Therapy 2023; 8(1) doi: 10.1038/s41392-022-01304-4
|
| 62 |
Pratsanee Hiengrach, Wimonrat Panpetch, Ariya Chindamporn, Asada Leelahavanichkul. Helicobacter pylori, Protected from Antibiotics and Stresses Inside Candida albicans Vacuoles, Cause Gastritis in Mice. International Journal of Molecular Sciences 2022; 23(15): 8568 doi: 10.3390/ijms23158568
|
| 63 |
SubratKumar Bhattamisra, LeePeng Hooi, LaiPey Shyan, LeeBoon Chieh, Mayuren Candasamy, PriyadarshiSoumyaranjan Sahu. Effect of geraniol and clarithromycin combination against gastric ulcers induced by acetic acid and Helicobacter pylori in rats. Pharmacognosy Research 2019; 11(4): 356 doi: 10.4103/pr.pr_21_19
|
| 64 |
Kuang Yunle, Wu Tong, Liu Jiyang, Wu Guojun. Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review. Helicobacter 2024; 29(1) doi: 10.1111/hel.13034
|
| 65 |
Shu-Peng Zou, Qian Cheng, Cheng-Yang Feng, Chan Xu, Ming-Hui Sun. Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant <i>Helicobacter pylori</i> strains: A network meta-analysis. World Journal of Clinical Cases 2022; 10(35): 12959-12970 doi: 10.12998/wjcc.v10.i35.12959
|
| 66 |
Zeeshan Umar, Jia-Wei Tang, Barry J. Marshall, Alfred Chin Yen Tay, Liang Wang.
Rapid diagnosis and precision treatment of
Helicobacter pylori
infection in clinical settings
. Critical Reviews in Microbiology 2024; : 1 doi: 10.1080/1040841X.2024.2364194
|
| 67 |
Ruiyu Wang, Shu Huang, Peiling Gan, Xiao Pan, Ping Wang, Xiaolin Zhong, Muhan Lü, Xian Zhou, Xiaowei Tang. States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis. Helicobacter 2023; 28(4) doi: 10.1111/hel.12986
|
| 68 |
Lyudmila Boyanova, Ivailo Evstatiev, Daniel Yordanov, Rumyana Markovska, Ivan Mitov. Three unsuccessful treatments of Helicobacter pylori infection by a highly virulent strain with quadruple antibiotic resistance. Folia Microbiologica 2016; 61(4): 307 doi: 10.1007/s12223-015-0439-2
|
| 69 |
Zhenxing Li, Kunfeng Yan, Xiaorong Dai, Weiwei Rong. Study on the clinical efficacy of 14-day vonoprazan-based triple regimen in obese patients with Helicobacter pylori infection. Journal of Chemotherapy 2024; : 1 doi: 10.1080/1120009X.2024.2405353
|
| 70 |
Corinne Raïssa Ngnameko, Frederic Nico Njayou, Muinah Fowora, Fredy Brice Simo Nemg, Paul Moundipa Fewou, Stella Ifeanvi Smith. Inhibitory effect of medicinal plants from Cameroon on the growth and adhesion of Helicobacter pylori. European Journal of Integrative Medicine 2019; 30: 100957 doi: 10.1016/j.eujim.2019.100957
|
| 71 |
Uriel Gomez-Ramirez, Pedro Valencia-Mayoral, Sandra Mendoza-Elizalde, Juan Rafael Murillo-Eliosa, Fortino Solórzano Santos, Araceli Contreras-Rodríguez, Gerardo Zúñiga, Pamela Aguilar-Rodea, Verónica Leticia Jiménez-Rojas, Juan Carlos Vigueras Galindo, Marcela Salazar-García, Norma Velázquez-Guadarrama. Role of Helicobacter pylori and Other Environmental Factors in the Development of Gastric Dysbiosis. Pathogens 2021; 10(9): 1203 doi: 10.3390/pathogens10091203
|
| 72 |
Wen-Juan Yang, He-Ping Zhao, Yan Yu, Ji-Han Wang, Lei Guo, Jun-Ye Liu, Jie Pu, Jing Lv. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World Journal of Gastroenterology 2023; 29(16): 2452-2468 doi: 10.3748/wjg.v29.i16.2452
|
| 73 |
György Miklós Buzás. Helicobacter pylori– 2014. Orvosi Hetilap 2015; 156(6): 203 doi: 10.1556/OH.2015.30097
|
| 74 |
Ki-Young Lee, Bong-Jin Lee. Solution NMR studies onHelicobacter pyloriproteins for antibiotic target discovery. Expert Opinion on Drug Discovery 2016; 11(7): 681 doi: 10.1080/17460441.2016.1189411
|
| 75 |
Paulina Ortiz-Ramírez, Beatriz Hernández-Ochoa, Daniel Ortega-Cuellar, Abigail González-Valdez, Víctor Martínez-Rosas, Laura Morales-Luna, Roberto Arreguin-Espinosa, Rosa Angélica Castillo-Rodríguez, Luis Miguel Canseco-Ávila, Noemi Cárdenas-Rodríguez, Verónica Pérez de la Cruz, Alba Mónica Montiel-González, Fernando Gómez-Chávez, Saúl Gómez-Manzo. Biochemical and Kinetic Characterization of the Glucose-6-Phosphate Dehydrogenase from Helicobacter pylori Strain 29CaP. Microorganisms 2022; 10(7): 1359 doi: 10.3390/microorganisms10071359
|
| 76 |
Zan Wang, Shu-Li Shao, Xiao-Han Xu, Xue Zhao, Ming-Yi Wang, Ai Chen, Hai-Yan Cong.
Helicobacter Pylori
and Gastric Microbiota Homeostasis: Progress and Prospects
. Future Microbiology 2023; 18(2): 137 doi: 10.2217/fmb-2022-0102
|
| 77 |
Cristina Maria Marginean, Ramona Cioboata, Mihai Olteanu, Corina Maria Vasile, Mihaela Popescu, Alin Iulian Silviu Popescu, Simona Bondari, Denisa Pirscoveanu, Iulia Cristina Marginean, George Alexandru Iacob, Mihai Daniel Popescu, Mihaela Stanciu, Paul Mitrut. The Importance of Accurate Early Diagnosis and Eradication in Helicobacter pylori Infection: Pictorial Summary Review in Children and Adults. Antibiotics 2022; 12(1): 60 doi: 10.3390/antibiotics12010060
|
| 78 |
Hye Yoon Park, Eun Jeong Kang, Dong Gun Kim, Ki Ju Kim, Jin Woo Choi, Su Youn Nam, Yong Hwan Kwon, Hyun Seok Lee, Seong Woo Jeon. High and Frequent Dose of Dexlansoprazole and Amoxicillin Dual Therapy for Helicobacter pylori Infections: A Single Arm Prospective Study. Korean Journal of Gastroenterology 2017; 70(4): 176 doi: 10.4166/kjg.2017.70.4.176
|
| 79 |
Marcello Fiorani, Ege Tohumcu, Livio Enrico Del Vecchio, Serena Porcari, Giovanni Cammarota, Antonio Gasbarrini, Gianluca Ianiro. The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota. Antibiotics 2023; 12(4): 765 doi: 10.3390/antibiotics12040765
|
| 80 |
Javier P. Gisbert, Adrian G. McNicholl. Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies. Helicobacter 2017; 22(4) doi: 10.1111/hel.12392
|
| 81 |
Chan-Juan Fan. Efficacy assessment of diverse antibiotic combinations in bismuth quadruple regimens and risk factors for Helicobacter pylori eradication: a retrospective single-center study in China. International Journal of Clinical and Experimental Medicine 2024; 17(5): 75 doi: 10.62347/SMLE6245
|
| 82 |
Osamah Ahmad Hakami, Refah Asheer Alsubaie, Bayan Abdulhadi Albaqami, Haifa Matar Almutlaq, Nourah Mushabab Alqahtani, Manal Alkhonezan, Farah Fahad Almuqrin, Abdullah Hussien Alghamdi, Abdullah Abdulaziz Alaryni, Rayan Abubakker Qutob. Knowledge and Perception of Physicians of Different Specialties in Saudi Arabia Toward Helicobacter pylori. Journal of Multidisciplinary Healthcare 2023; : 763 doi: 10.2147/JMDH.S403999
|
| 83 |
Lei Zhang, Fei Yu, Yue Zhang, Peifeng Li. Implications of lncRNAs in Helicobacter pylori-associated gastrointestinal cancers: underlying mechanisms and future perspectives. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1392129
|
| 84 |
Uriel Gomez-Ramirez, Carolina G. Nolasco-Romero, Araceli Contreras-Rodríguez, Gerardo Zuñiga, Sandra Mendoza-Elizalde, Francisco-Javier Prado-Galbarro, Fernando Pérez Aguilar, Jonatan Elihu Pedraza Tinoco, Pedro Valencia-Mayoral, Norma Velázquez-Guadarrama. Dysbiosis by Eradication of Helicobacter pylori Infection Associated with Follicular Gastropathy and Pangastropathy. Microorganisms 2023; 11(11): 2748 doi: 10.3390/microorganisms11112748
|
| 85 |
Santino Caserta, Claudia Genovese, Nicola Cicero, Sebastiano Gangemi, Alessandro Allegra. The Anti-Cancer Effect of Cinnamon Aqueous Extract: A Focus on Hematological Malignancies. Life 2023; 13(5): 1176 doi: 10.3390/life13051176
|
| 86 |
NohaMahmoud Elkhodary, KhaledAbdalkader Farrag, AmanyMahmoud Elokaby, GamalAbd El-Hay Omran. Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial. Indian Journal of Pharmacology 2020; 52(5): 356 doi: 10.4103/ijp.IJP_364_19
|
| 87 |
Huili Shen, Yijie Chen, Xiaohui Li, Jing Yan, Junjie Zhao, Demin Kong, Yanxia Shi, Zhihui Li, Jihong Wang, Na Shao, Zhenghui Wang, Xueliang Wu. Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/8266321
|
| 88 |
Michael G. Bruce, Dana Bruden, Deidra Newbrough, Debby A. Hurlburt, Thomas W. Hennessy, Julie M. Morris, Alisa L. Reasonover, Frank Sacco, Brian J. McMahon. The relationship between previous antimicrobial use, antimicrobial resistance and treatment outcome among Alaskans treated forHelicobacter pyloriinfection. GastroHep 2019; doi: 10.1002/ygh2.352
|
| 89 |
Hammad Ullah, Alessandro Di Minno, Cristina Santarcangelo, Haroon Khan, Jianbo Xiao, Carla Renata Arciola, Maria Daglia. Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials. Molecules 2021; 26(8): 2272 doi: 10.3390/molecules26082272
|
| 90 |
Yu Wang, Jiong Tang, Su Zhou, Tian-Tian Liang, Fang-Fang Wang, Hong Ning. Effectiveness and Safety of Rifaximin-Containing Regimens for Helicobacter pylori Eradication: Systematic Review – Are They Potential Eradication Regimens?. Infection and Drug Resistance 2022; : 3733 doi: 10.2147/IDR.S371131
|
| 91 |
Venkatesh Panthangi, Adrienne R Cyril Kurupp, Anjumol Raju, Gaurav Luthra, Mahrukh Shahbaz, Halah Almatooq, Paul Foucambert, Faith D Esbrand, Sana Zafar, Safeera Khan. Association Between Helicobacter pylori Infection and the Risk of Pancreatic Cancer: A Systematic Review Based on Observational Studies. Cureus 2022; doi: 10.7759/cureus.28543
|
| 92 |
Mahnaz Shahabimehr, Masoud Alebouyeh, Nastaran Farzi, Arash Mahboubi, Reza Taslimi, Mohammad Reza Zali. Resistance Rate and Minimum Inhibitory Concentration of Metronidazole Among Helicobacter pylori Strains in Tehran, Iran. Archives of Clinical Infectious Diseases 2016; 11(2) doi: 10.5812/archcid.34478
|
| 93 |
Chi-Tan Hu. High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection – A review of the strengths, weaknesses, and proposed solutions. Tzu Chi Medical Journal 2022; 34(3): 303 doi: 10.4103/tcmj.tcmj_185_21
|
| 94 |
Daniela Lopes-de-Campos, Catarina Leal Seabra, Rita M. Pinto, Mateusz Adam Słowiński, Bruno Sarmento, Cláudia Nunes, M. Cristina L. Martins, Salette Reis. Targeting and killing the Ever-Challenging ulcer bug. International Journal of Pharmaceutics 2022; 617: 121582 doi: 10.1016/j.ijpharm.2022.121582
|
| 95 |
Malek Zihlif, Banan Bashaireh, Mohammed Rashid, Zaid Almadani, Yazun Jarrar. Effect of major CYP2C19 genetic polymorphisms on Helicobacter pylori eradication based on different treatment regimens. Biomedical Reports 2021; 16(1) doi: 10.3892/br.2021.1485
|
| 96 |
Zahyra Kaouah, Julien M. Buyck, Maxime Pichon, Christophe Burucoa, Laure Prouvensier, Jeremy Moreau, Sandrine Marchand, Julie Cremniter, Nicolas Grégoire. In vitro efficacy of combinations of antibiotics used in clinical practice on clinical isolates of Helicobacter pylori. Helicobacter 2024; 29(3) doi: 10.1111/hel.13081
|
| 97 |
Chia-Jung Kuo, Chun-Wei Chen, Puo-Hsien Le, Jun-Te Hsu, Cheng-Yu Lin, Hao-Tsai Cheng, Ming-Yao Su, Chun-Jung Lin, Cheng-Tang Chiu. Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819870960
|
| 98 |
Kaifei Xu, Shuo Sheng, Feng Zhang. Relationship Between Gut Bacteria and Levodopa Metabolism. Current Neuropharmacology 2023; 21(7): 1536 doi: 10.2174/1570159X21666221019115716
|
| 99 |
Thukten Chophel, Sangay Tshering, Namkha Dorji, Ugyen Tshomo. Stomach Cancer Screening Services of Bhutan. Indian Journal of Surgery 2023; 85(3): 489 doi: 10.1007/s12262-022-03519-9
|
| 100 |
I-Ting Wu, Seng-Kee Chuah, Chen-Hsiang Lee, Chih-Ming Liang, Lung-Sheng Lu, Yuan-Hung Kuo, Yi-Hao Yen, Ming-Luen Hu, Yeh-Pin Chou, Shih-Cheng Yang, Chung-Mou Kuo, Chung-Huang Kuo, Chun-Chih Chien, Yu-Shao Chiang, Shue-Shian Chiou, Tsung-Hui Hu, Wei-Chen Tai. Five-year sequential changes in secondary antibiotic resistance of <italic>Helicobacter pylori</italic> in Taiwan. World Journal of Gastroenterology 2015; 21(37): 10669-10674 doi: 10.3748/wjg.v21.i37.10669
|
| 101 |
Muhammad Miftahussurur, Yoshio Yamaoka. Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective. Molecules 2015; 20(4): 6068 doi: 10.3390/molecules20046068
|
| 102 |
Hidetaka Okubo, Junichi Akiyama, Masao Kobayakawa, Megumi Kawazoe, Saori Mishima, Yusuke Takasaki, Naoyoshi Nagata, Takayuki Shimada, Chizu Yokoi, Shiori Komori, Kana Kimura, Yuya Hisada, Eri Iwata, Kazuhiro Watanabe, Naohiro Yanagisawa, Sho Shiroma, Akira Shimomura, Koki Okahara, Hourin Cho, Naomi Uemura. Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility. Journal of Gastroenterology 2020; 55(11): 1054 doi: 10.1007/s00535-020-01723-6
|
| 103 |
Merve Öztekin, Birsen Yılmaz, Duygu Ağagündüz, Raffaele Capasso. Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects. Diseases 2021; 9(4): 66 doi: 10.3390/diseases9040066
|
| 104 |
Tianxing Lin, Lei Huang, Ningna Cheng, Yuzhen Wang, Zhen Ning, Shaokang Huang, Yuanhua Wu, Tianbao Chen, Songkun Su, Yan Lin. The in vitro and in vivo antibacterial activities of uniflorous honey from a medicinal plant, Scrophularia ningpoensis Hemsl., and characterization of its chemical profile with UPLC-MS/MS. Journal of Ethnopharmacology 2022; 296: 115499 doi: 10.1016/j.jep.2022.115499
|
| 105 |
Masoud Keikha, Parvin Askari, Kiarash Ghazvini, Mohsen Karbalaei. Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 2022; 29: 420 doi: 10.1016/j.jgar.2021.10.019
|
| 106 |
Ying Liang, Jiaqian Yan, Ziqi Chen, Qing Gu, Ping Li. Antibacterial Effects of Bacteriocin PLNC8 against Helicobacter pylori and Its Potential Mechanism of Action. Foods 2022; 11(9): 1235 doi: 10.3390/foods11091235
|
| 107 |
Julio Valle Muñoz, Pablo Muñoz Gómez, Cristian Sierra Bernal, Eva de Andrés , César Gómez Hernando, Rafael Gómez Rodríguez. Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance. Revista Española de Enfermedades Digestivas 2019; 111 doi: 10.17235/reed.2019.6198/2019
|
| 108 |
Man-Li Zhang, Yu-Xin Fan, Rui Meng, Wen-Ke Cai, Sun-Jun Yin, Tao Zhou, Yan-Hua Huang, Ping Wang, Fang-Fang Jiang, Mei Yang, Gong-Hao He. Proton Pump Inhibitors and Cancer Risk. American Journal of Clinical Oncology 2022; 45(11): 475 doi: 10.1097/COC.0000000000000949
|
| 109 |
Ghazal Mohseni, Juan Li, Abakundana Nsenga Ariston Gabriel, Lutao Du, Yun-shan Wang, Chuanxin Wang. The Function of cGAS-STING Pathway in Treatment of Pancreatic Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.781032
|
| 110 |
Mayo Hirabayashi, Manami Inoue, Norie Sawada, Eiko Saito, Sarah K. Abe, Akihisa Hidaka, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Shoichiro Tsugane. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-42365-w
|
| 111 |
Guangqin Xu, Shaoze Ma, Liyan Dong, Nahum Mendez-Sanchez, Hongyu Li, Xingshun Qi, Alessandro Granito. Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2023; 2023: 1 doi: 10.1155/2023/5521239
|
| 112 |
Guang-Hong Jheng, I-Chen Wu, Hsiang-Yao Shih, Meng-Chieh Wu, Fu-Chen Kuo, Huang-Ming Hu, Chung-Jung Liu, Wen-Hung Hsu, Chi-Tan Hu, Ming-Jong Bair, Chao-Hung Kuo, Deng-Chyang Wu, Ping-I Hsu. Comparison of Second-Line Quadruple Therapies with or without Bismuth forHelicobacter pyloriInfection. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/163960
|
| 113 |
Pei Zhou, Yawen Hu, Xiaoyan Wang, Luxuan Shen, Xinghao Liao, Yajuan Zhu, Jiadong Yu, Fulei Zhao, Yi Zhou, Hengshui Shen, Jiong Li. Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.877939
|
| 114 |
John Y. Kao, June S. Almenoff, Dana D. Portenier, Kely L. Sheldon.
Helicobacter pylori
eradication by low‐dose rifabutin triple therapy (RHB‐105) is unaffected by high body mass index
. GastroHep 2021; 3(7): 426 doi: 10.1002/ygh2.494
|
| 115 |
Tugce Gur Maz, H. Burak Caliskan, Irfan Capan, Burcu Caliskan, Berrin Özçelik, Erden Banoglu. Design, Synthesis and Evaluation of Aryl‐Tailored Oxadiazole‐thiones as New Urease Inhibitors. ChemistrySelect 2023; 8(8) doi: 10.1002/slct.202204449
|
| 116 |
Ummay Mahfuza Shapla, Jinat Raihan, Asiful Islam, Fahmida Alam, Naeem Solayman, Siew Hua Gan, Sakib Hossen, Ibrahim Khalil. Propolis: The future therapy against Helicobacter pylori-mediated gastrointestinal diseases. Journal of Applied Biomedicine 2018; 16(2): 81 doi: 10.1016/j.jab.2017.10.007
|
| 117 |
Qian Hu, Ze Peng, Lingli Li, Xin Zou, Lijun Xu, Jing Gong, Ping Yi. The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Frontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01694
|
| 118 |
Furui Zhang, Linhan Ni, Zhen Zhang, Xuegang Luo, Xuequan Wang, Wenmiao Zhou, Jiale Chen, Jing Liu, Yuliang Qu, Kunmei Liu, Le Guo. Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection. Microbial Cell Factories 2024; 23(1) doi: 10.1186/s12934-024-02321-4
|
| 119 |
Yujia Ke, Cheng Tan, Junhai Zhen, Weiguo Dong. Global status and trends of gastric cancer and gastric microbiota research: a bibliometric analysis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1341012
|
| 120 |
Meng-Shu Hsieh, Fu-Chen Kuo, Meng-Chieh Wu, Jiunn-Wei Wang, Chung-Jung Liu, Neng-Sheng Chu, Pei-Yun Tsai, Ping-I Hsu, I-Chen Wu, Jeng-Yih Wu, Deng-Chyang Wu, Fang-Jung Yu, Chao-Hung Kuo. Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial. Journal of the Formosan Medical Association 2022; 121(8): 1450 doi: 10.1016/j.jfma.2021.10.011
|
| 121 |
M. Xia, H. Chen, S. Liu.
The synergy of resveratrol and alcohol against
Helicobacter pylori
and underlying anti‐
Helicobacter pylori
mechanism of resveratrol
. Journal of Applied Microbiology 2020; 128(4): 1179 doi: 10.1111/jam.14531
|
| 122 |
Vincent J. Venditto, David J. Feola. Delivering macrolide antibiotics to heal a broken heart – And other inflammatory conditions. Advanced Drug Delivery Reviews 2022; 184: 114252 doi: 10.1016/j.addr.2022.114252
|
| 123 |
Mariel de Barros, Luisa Mota da Silva, Thaise Boeing, Lincon Bordignon Somensi, Benhur Judah Cury, Ligia de Moura Burci, José Roberto Santin, Sérgio Faloni de Andrade, Franco Delle Monache, Valdir Cechinel-Filho. Pharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis (Brazilian arnica) and its components quercitrin and afzelin in rodents. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(4): 403 doi: 10.1007/s00210-015-1208-0
|
| 124 |
Yantong Li, Limin Li, Wenmeng Yin, Juyi Wan, Xiaolin Zhong. Bibliometric analysis of the correlation between H. pylori and inflammatory bowel disease. JGH Open 2024; 8(8) doi: 10.1002/jgh3.70014
|
| 125 |
Hauberline Domegne Mikwangock, Alfred Ngenge Tamfu, André Perfusion Amang, Gael Tchokomeni Siwe, Christophe Mezui, Selcuk Kucukaydin, Enonchong George Enow-Orock, Paul Vernyuy Tan, Valeria Pasciu. Chronic Gastric Ulcer Healing Actions of the Aqueous Extracts of Staple Plant Foods of the North‐West, Adamawa, and West Regions of Cameroon. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/2657278
|
| 126 |
Satoru Mizutani, Yu Takahashi, Takeshi Shimamoto, Hideki Nakagawa, Hiroyuki Hisada, Kaori Oshio, Dai Kubota, Hiroya Mizutani, Daisuke Ohki, Yoshiki Sakaguchi, Seiichi Yakabi, Keiko Niimi, Naomi Kakushima, Yosuke Tsuji, Ryoichi Wada, Nobutake Yamamichi, Mitsuhiro Fujishiro. Performing the ABC Method Twice for Gastric Cancer Risk Stratification: A Retrospective Study Based on Data from a Large-Scale Screening Facility. Diagnostics 2023; 13(7): 1284 doi: 10.3390/diagnostics13071284
|
| 127 |
Anam Naz, Tahreem Zaheer, Hamza Arshad Dar, Faryal Mehwish Awan, Ayesha Obaid, Shifa Tariq Ashraf, Rehan Zafar Paracha, Arif Malik, Amjad Ali. A Multi-Method and Structure-Based In Silico Vaccine Designing Against Helicobacter pylori Employing Immuno-Informatics Approach. Current Proteomics 2021; 18(2): 237 doi: 10.2174/1570164617999200414120231
|
| 128 |
Hongjin Tao, Fansen Meng, Yu Zhou, Jiao Fan, Jing Liu, Yingjie Han, Benjamin B. Sun, Gangshi Wang, Jennifer Gaddy. Transcriptomic and Functional Approaches Unveil the Role of tmRNA in Zinc Acetate Mediated Levofloxacin Sensitivity in Helicobacter pylori. Microbiology Spectrum 2022; 10(6) doi: 10.1128/spectrum.01152-22
|
| 129 |
Mengjuan Xuan, Xinyu Gu, Yingru Liu, Li Yang, Yi Li, Di Huang, Juan Li, Chen Xue. Intratumoral microorganisms in tumors of the digestive system. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01425-5
|
| 130 |
Guoguo Jin, Kangdong Liu, Zhiping Guo, Zigang Dong. Precision therapy for cancer prevention by targeting carcinogenesis. Molecular Carcinogenesis 2024; 63(11): 2045 doi: 10.1002/mc.23798
|
| 131 |
Guner Kilic, Gulce Ecem Kilic, Adnan Özkahraman, Sevki Konur, Ramazan Dertli, Yusuf Kayar. Amoxicillin, gemifloxacin and rabeprazole, as first-line Helicobacter pylori therapy in clinical practice: A pilot study. Medicine 2024; 103(18): e38012 doi: 10.1097/MD.0000000000038012
|
| 132 |
Claudia Lombardo, Rosanna Fazio, Marta Sinagra, Giuseppe Gattuso, Federica Longo, Cinzia Lombardo, Mario Salmeri, Guido Nicola Zanghì, Carla Agata Erika Loreto. Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives. Journal of Personalized Medicine 2024; 14(11): 1083 doi: 10.3390/jpm14111083
|
| 133 |
Muhammad Miftahussurur, Yoshio Yamaoka. Helicobacter pylori Research. 2016; : 519 doi: 10.1007/978-4-431-55936-8_23
|
| 134 |
Li Cen, Jiaqi Pan, Boyan Zhou, Chaohui Yu, Youming Li, Weixing Chen, Zhe Shen. Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta‐analysis. Helicobacter 2018; 23(1) doi: 10.1111/hel.12457
|
| 135 |
Pere Lloret, Pau Cano, Eva Musulen, Debora Gil. Advances in Computational Collective Intelligence. Communications in Computer and Information Science 2024; 2165: 73 doi: 10.1007/978-3-031-70248-8_6
|
| 136 |
Nathan E. Agbor, Seraphine N. Esemu, Lucy M. Ndip, Nicoline F. Tanih, Stella I. Smith, Roland N. Ndip. Helicobacter pylori in patients with gastritis in West Cameroon: prevalence and risk factors for infection. BMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3662-5
|
| 137 |
Xiaoyin Peng, Yumei Liang, Yan Liu, Juan Zhang, Yong Chen, Qi Zhang, Xiangchun Zeng, Li Huang. The Comparison of the Clinical Efficacy and Drug Tissue Distribution of Furazolidone and Tetracycline-quadruple Therapy in Helicobacter pylori Eradication. Journal of Clinical Gastroenterology 2024; doi: 10.1097/MCG.0000000000002044
|
| 138 |
Maliheh Safavi, Reyhaneh Sabourian, Alireza Foroumadi. Treatment of <i>Helicobacter pylori</i> infection: Current and future insights. World Journal of Clinical Cases 2016; 4(1): 5-19 doi: 10.12998/wjcc.v4.i1.5
|
| 139 |
Bumjo Oh, Bong‐Soo Kim, Ji Won Kim, Jong Seung Kim, Seong‐Joon Koh, Byeong Gwan Kim, Kook Lae Lee, Jongsik Chun. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial. Helicobacter 2016; 21(3): 165 doi: 10.1111/hel.12270
|
| 140 |
|
| 141 |
Soo Yeon Choi, Na Rae Lim, Woo Chul Chung. Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(2): 118 doi: 10.7704/kjhugr.2022.0058
|
| 142 |
Jacek Budzyński. Helicobacter pylori eradication: Not only early consequences. EBioMedicine 2018; 35: 8 doi: 10.1016/j.ebiom.2018.08.051
|
| 143 |
Saumya Das, Manas Kumar Das, Rajashree Das, Valentina Gehlot, Shweta Mahant, Papiya Mitra Mazumder, Sanjita Das, Neha Falls, Vikas Kumar. Isolation, characterization of Berberine from Berberis aristata DC for eradication of resistant Helicobacter pylori. Biocatalysis and Agricultural Biotechnology 2020; 26: 101622 doi: 10.1016/j.bcab.2020.101622
|
| 144 |
Shuanghui Luo, Wei Liu, Zhiqin Zeng, Feng Ye, Chupeng Hu, Ningyin Xu, An Huang, Tao Xi, Yingying Xing. Toxic adjuvants alter the function and phenotype of dendritic cells to initiate adaptive immune responses induced by oral Helicobacter pylori vaccines. Helicobacter 2018; 23(6) doi: 10.1111/hel.12536
|
| 145 |
Freya Wellhöner, Nico Döscher, Tammo Lambert Tergast, Marius Vital, Iris Plumeier, Silke Kahl, Andrej Potthoff, Michael Peter Manns, Benjamin Maasoumy, Heiner Wedemeyer, Markus Cornberg, Dietmar Helmut Pieper, Benjamin Heidrich. The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients. Scandinavian Journal of Gastroenterology 2019; 54(8): 1033 doi: 10.1080/00365521.2019.1647280
|
| 146 |
Colin W. Howden, Stuart J. Spechler, Michael F. Vaezi, A. Mark Fendrick, Christian Atkinson, Corey Pelletier, Rinu Jacob, Stephen Brunton. Study of Acid-related Disorders: Real-world Physician and Patient Perspectives on Burden of Helicobacter pylori Infection. Gastro Hep Advances 2022; 1(2): 231 doi: 10.1016/j.gastha.2021.12.005
|
| 147 |
|